Petra reports Jordan workshop on pharmaceutical-research regulation

Petra reports the opening of a workshop on pharmaceutical studies and clinical-trial rules organised by the ACDIMA studies centre with Jordan’s medicines regulator and pharmaceutical-manufacturers association. JFDA director Rana Obeidat also said an upcoming research conference’s themes would be announced. The report does not establish new regulations, successful trials, safer medicines or a confirmed conference schedule.

Yazan Editör Ekibi · Published 11 Eki 2026 · Updated 11 Eki 2026

Kaynak yayımı: 11 Eki 2026

Aciliyet: Bağlam · Kanıt: Kaynağı belirtilen iddia

Kaynakların ortaya koydukları

Petra reports the workshop and quotes JFDA director Rana Obeidat and pharmaceutical-manufacturers association secretary-general Hanan Al-Sboul. Their descriptions of sector leadership and future plans are institutional assessments, not independently verified research performance; those promotional claims are not adopted in the headline or summary. No full workshop materials, amended regulations, conference dates or independent training assessment were obtained. No material contrary account was found. This education event is distinct from JFDA's earlier online-services trial. The page displays October 11 at 22:12:49 without a timezone; noon UTC is a publication-date reference only, not an opening clock. The integer country coordinate omits research premises and participants. No community label, medical advice or treatment claim is included.

Kanıtın son kontrolü: 11 Eki 2026 20:22 UTC.

11 Eki 2026 20:22 UTC — First published as attributed regulatory training, not a rule change, clinical result or medical recommendation.

Kaynaklar

Jordan News Agency (Petra) Devlet haber ajansı
state news-agency reporting of the workshop opening and statements by JFDA and industry representatives

Haritada görüntüle · Hata bildirin